Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Connor

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Cannabis and Cannabinoid Research|September 28, 2019
Absence of Entourage: Terpenoids Commonly Found in <i>Cannabis sativa</i> Do Not Modulate the Functional Activity of Δ<sup>9</sup>-THC at Human CB<sub>1</sub> and CB<sub>2</sub> ReceptorsMarina Santiago, Shivani Sachdev, Jonathon C Arnold, et al.
Journal of Medicinal Chemistry|July 24, 2015
Distinct Temporal Fingerprint for Cyclic Adenosine Monophosphate (cAMP) Signaling of Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid ReceptorsErin E Cawston, Mark Connor, Vincenzo Di Marzo, et al.
British Journal of Pharmacology|June 28, 2005
Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphineElena E Bagley, Billy C H Chieng, MacDonald J Christie, et al.
Molecular Pain|November 19, 2008
Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal greyHyo-Jin Jeong, David Chenu, Emma E Johnson, et al.
ACS Chemical Neuroscience|January 29, 2019
Dark Classics in Chemical Neuroscience: Δ<sup>9</sup>-TetrahydrocannabinolSamuel D Banister, Jonathon C Arnold, Mark Connor, et al.
Pharmacology Research & Perspectives|February 27, 2020
Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonistsShivani Sachdev, Samuel D Banister, Marina Santiago, et al.
European Journal of Medicinal Chemistry|July 19, 2019
Strategies to develop selective CB<sub>2</sub> receptor agonists from indole carboxamide synthetic cannabinoidsMichael Moir, Samuel Lane, Felcia Lai, et al.
European Journal of Medicinal Chemistry|December 15, 2020
The discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine cannabinoid type 2 receptor agonistMichael Moir, Samuel Lane, Andrew P Montgomery, et al.
Frontiers in Epidemiology|May 20, 2026
Detecting comorbidity patterns in rare disease patients with machine learningBenjamin Mark Connor, Claire Hill, Lu Bai, et al.
Neuropharmacology|February 18, 2021
Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitroChris Bladen, Somayeh Mirlohi, Marina Santiago, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Cannabis and Cannabinoid Research|September 28, 2019
Absence of Entourage: Terpenoids Commonly Found in <i>Cannabis sativa</i> Do Not Modulate the Functional Activity of Δ<sup>9</sup>-THC at Human CB<sub>1</sub> and CB<sub>2</sub> ReceptorsMarina Santiago, Shivani Sachdev, Jonathon C Arnold, et al.
Journal of Medicinal Chemistry|July 24, 2015
Distinct Temporal Fingerprint for Cyclic Adenosine Monophosphate (cAMP) Signaling of Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid ReceptorsErin E Cawston, Mark Connor, Vincenzo Di Marzo, et al.
British Journal of Pharmacology|June 28, 2005
Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphineElena E Bagley, Billy C H Chieng, MacDonald J Christie, et al.
Molecular Pain|November 19, 2008
Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal greyHyo-Jin Jeong, David Chenu, Emma E Johnson, et al.
ACS Chemical Neuroscience|January 29, 2019
Dark Classics in Chemical Neuroscience: Δ<sup>9</sup>-TetrahydrocannabinolSamuel D Banister, Jonathon C Arnold, Mark Connor, et al.
Pharmacology Research & Perspectives|February 27, 2020
Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonistsShivani Sachdev, Samuel D Banister, Marina Santiago, et al.
European Journal of Medicinal Chemistry|July 19, 2019
Strategies to develop selective CB<sub>2</sub> receptor agonists from indole carboxamide synthetic cannabinoidsMichael Moir, Samuel Lane, Felcia Lai, et al.
European Journal of Medicinal Chemistry|December 15, 2020
The discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine cannabinoid type 2 receptor agonistMichael Moir, Samuel Lane, Andrew P Montgomery, et al.
Frontiers in Epidemiology|May 20, 2026
Detecting comorbidity patterns in rare disease patients with machine learningBenjamin Mark Connor, Claire Hill, Lu Bai, et al.
Neuropharmacology|February 18, 2021
Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitroChris Bladen, Somayeh Mirlohi, Marina Santiago, et al.
Pageof 11